Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins

AIDS Research and Human Retroviruses

Volumn 27, Issue 6, 2011, Pages 647-654

  Campbell, Grant R ^a   Watkins, Jennifer D ^b,c   Loret, Erwann P ^b   Spector, Stephen A ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; TRANSACTIVATOR PROTEIN; ZINC ION;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CHELATION; CIRCULAR DICHROISM; EXCITOTOXICITY; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIA; MACROPHAGE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TRANSCRIPTION REGULATION; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; CELL DEATH; HIPPOCAMPUS; HIV-1; NEURONS; PROTEIN BINDING; RATS; SPECTRUM ANALYSIS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; ZINC;

EID: 79957626305     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0192     Document Type: Article

References (52)

1. Mahadevan A, Shankar SK, Satishchandra P, et al.: Characterization of human immunodeficiency virus (HIV)-infected cells in infiltrates associated with CNS opportunistic infections in patients with HIV clade C infection. J Neuropathol Exp Neurol 2007;66:799-808 (Pubitemid 47360955)
2. Grant I, Sacktor N, and McArthur J: HIV neurocognitive disorders. In: The Neurology of AIDS (Gendelman HE, Grant I, Everall I, Lipton SA, Swindells S, Eds.), 2nd ed. Oxford University Press, London, UK, 2005, pp. 357-373
3. Siddappa NB, Dash PK, Mahadevan A, et al.: Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 2004;42:2742-2751 (Pubitemid 38747530)
4. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 AIDS 2006;20:W13-23 (Pubitemid 44611051)
5. Satishchandra P, Nalini A, Gourie-Devi M, et al.: Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res 2000;111:14-23 (Pubitemid 30213883)
6. Shankar SK, Mahadevan A, Satishchandra P, et al.: Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 2005;121:468-488 (Pubitemid 40691377)
7. Riedel D, Ghate M, Nene M, et al.: Screening for human immunodeficiency virus (HIV) dementia in an HIV clade Cinfected population in India. J Neurovirol 2006;12:34-38
8. Gupta JD, Satishchandra P, Gopukumar K, et al.: Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol 2007;13:195-202 (Pubitemid 47053787)
9. Adle-Biassette H, Chretien F, Wingertsmann L, et al.: Neuronalapoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999;25:123-133 (Pubitemid 29221762)
10. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, and Keohane C: Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20: 146-155
11. Zink MC, Suryanarayana K, Mankowski JL, et al.: High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999;73:10480-10488
12. Gonzalez-Scarano F and Martin-Garcia J: The neuropathogenesis of AIDS. Nat Rev Immunol 2005;5:69-81 (Pubitemid 40070332)
13. King JE, Eugenin EA, Buckner CM, and Berman JW: HIV tat and neurotoxicity. Microbes Infect 2006;8:1347-1357 (Pubitemid 43842005)
14. Westendorp MO, Frank R, Ochsenbauer C, et al.: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 Nature 1995;375:497-500
15. Xiao H, Neuveut C, Tiffany HL, et al.: Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1 Proc Natl Acad Sci USA 2000;97: 11466-11471
16. Banks WA, Robinson SM, and Nath A: Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol 2005;193: 218-227 (Pubitemid 40463283)
17. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, and Walker SM: Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994;54: 19-28 (Pubitemid 24312618)
18. Nath A, Geiger JD, Mattson MP, Magnuson DSK, Jones M, and Berger JR: Role of viral proteins in HIV-1 neuropathogenesis with emphasis on Tat. NeuroAIDS 1998;1:1-9
19. Hudson L, Liu J, Nath A, et al.: Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 2000;6:145-155 (Pubitemid 30303573)
20. Del Valle L, Croul S, Morgello S, Amini S, Rappaport J, and Khalili K: Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol 2000;6:221-228 (Pubitemid 30447166)
21. Tardieu M, Hery C, Peudenier S, Boespflug O, and Montagnier L: Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-tocell adhesion. Ann Neurol 1992;32:11-17
22. Song L, Nath A, Geiger JD, Moore A, and Hochman S: Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol 2003;9:399-403 (Pubitemid 36874714)
23. Chandra T, Maier W, Konig HG, et al.: Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Neuroscience 2005;134:145-153 (Pubitemid 40943641)
24. Mishra M, Vetrivel S, Siddappa NB, Ranga U, and Seth P: Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: Significance of dicysteine C30C31 motif. Ann Neurol 2008; 63:366-376 (Pubitemid 351499866)
25. Rao VR, Sas AR, Eugenin EA, et al.: HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci 2008;28:10010-10016
26. Samikkannu T, Saiyed ZM, Rao KV, et al.: Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein. AIDS Res Hum Retroviruses 2009;25:329-335
27. Jones M, Olafson K, Del Bigio MR, Peeling J, and Nath A: Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 1998;57:563-570
28. Li W, Huang Y, Reid R, et al.: NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 2008; 28:12190-12198
29. Campbell GR, Watkins JD, Singh KK, Loret EP, and Spector SA: Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 2007;81:5919-5928 (Pubitemid 46847028)
30. Wong JK, Campbell GR, and Spector SA: Differential induction of interleukin-10 in monocytes by HIV-1 Clade B and Clade C Tat proteins. J Biol Chem 2010;285:18319-18325
31. Barany G and Merrifield RB: Solid phase peptide synthesis. In: The Peptide: Analysis, Synthesis, Biology (Gross E, Meinhofer J, Eds.), Vol 2 Academic Press, New York, 1980, pp. 1- 284
32. Campbell GR, Pasquier E, Watkins J, et al.: The glutaminerich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem 2004;279:48197-48204 (Pubitemid 39540975)
33. Campbell GR, Watkins JD, Esquieu D, Pasquier E, Loret EP, and Sector SA: The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells. J Biol Chem 2005;280:38376-38382 (Pubitemid 43853734)
34. Campbell GR, Senkaali D, Watkins J, et al.: Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine 2007;25:8441-8447 (Pubitemid 350148112)
35. Koken SE, Greijer AE, Verhoef K, van Wamel J, Bukrinskaya AG, and Berkhout B: Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem 1994;269:8366-8375 (Pubitemid 24200255)
36. Gasteiger E, Hoogland C, Gattiker A, et al.: Protein identification and analysis tools on the ExPASy server. In: The Proteomics Protocols Handbook (Walker JM, Ed.). Humana Press, Totowa, NJ, 2005, pp. 571-607
37. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77
38. Frankel AD, Bredt DS, and Pabo CO: Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 1988;240:70-73
39. Huang HW and Wang KT: Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem Biophys Res Commun 1996;227:615-621
40. Egelé C, Barbier P, Didier P, et al.: Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat. Retrovirology 2008;5:62
41. Grégoire C, Péloponèse JM, Jr., Esquieu D, et al.: Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers 2001;62:324-335 (Pubitemid 33043003)
42. Watkins JD, Campbell GR, Halimi H, and Loret EP: Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology 2008;5:83
43. Péloponèse JM, Jr., Collette Y, Grégoire C, et al.: Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J Biol Chem 1999;274:11473-11478
44. Paoletti P, Ascher P, andNeyton J:High-affinity zinc inhibition ofNMDANR1-NR2Areceptors. JNeurosci 1997;17:5711-5725
45. Chen CJ and Liao SL: Neurotrophic and neurotoxic effects of zinc on neonatal cortical neurons. Neurochem Int 2003; 42:471-479
46. Frankfurt OS and Krishan A: Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening. J Immunol Methods 2001;253:133-144 (Pubitemid 32522521)
47. Palm R, Sjostrom R, and Hallmans G: Optimized atomic absorption spectrophotometry of zinc in cerebrospinal fluid. Clin Chem 1983;29:486-491 (Pubitemid 13160755)
48. Ranga U, Shankarappa R, Siddappa NB, et al.: Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004;78:2586-2590 (Pubitemid 38228954)
49. Garber ME, Wei P, KewalRamani VN, et al.: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998;12:3512-3527 (Pubitemid 28553243)
50. Opi S, Péloponèse JM Jr, EsquieuD, et al.: Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine 2004;22:3105-3111 (Pubitemid 39037214)
51. Desfosses Y, Solis M, Sun Q, et al.: Regulation of human immunodeficiency virus type 1 gene expression by cladespecific Tat proteins. J Virol 2005;79:9180-9191 (Pubitemid 40934829)
52. Ammosova T, Berro R, Jerebtsova M, et al.: Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology 2006;3:78